CERRANO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.312
EU - Europa 742
AS - Asia 509
SA - Sud America 23
AF - Africa 17
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 2.623
Nazione #
US - Stati Uniti d'America 1.297
IT - Italia 241
CN - Cina 239
IE - Irlanda 92
SE - Svezia 85
DE - Germania 67
KR - Corea 66
SG - Singapore 53
FR - Francia 48
VN - Vietnam 34
IN - India 28
AT - Austria 25
ES - Italia 25
JP - Giappone 24
UA - Ucraina 24
FI - Finlandia 23
GB - Regno Unito 23
ID - Indonesia 15
BR - Brasile 14
CA - Canada 14
RU - Federazione Russa 13
TW - Taiwan 13
UZ - Uzbekistan 13
CH - Svizzera 11
PL - Polonia 11
AU - Australia 10
BY - Bielorussia 10
HK - Hong Kong 10
SN - Senegal 10
NL - Olanda 9
CO - Colombia 7
PT - Portogallo 7
HU - Ungheria 6
BE - Belgio 5
CZ - Repubblica Ceca 5
ZA - Sudafrica 5
EU - Europa 4
NZ - Nuova Zelanda 4
GR - Grecia 3
TR - Turchia 3
AP - ???statistics.table.value.countryCode.AP??? 2
BN - Brunei Darussalam 2
DK - Danimarca 2
LT - Lituania 2
LU - Lussemburgo 2
PH - Filippine 2
SA - Arabia Saudita 2
TH - Thailandia 2
AR - Argentina 1
BO - Bolivia 1
IR - Iran 1
LI - Liechtenstein 1
MU - Mauritius 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
RO - Romania 1
TN - Tunisia 1
Totale 2.623
Città #
Chandler 202
Fairfield 121
Beijing 109
Dublin 91
Ashburn 77
Torino 76
Houston 70
Woodbridge 49
Nyköping 47
Cambridge 46
Redwood City 46
Singapore 43
Wilmington 43
Medford 42
Seattle 39
Ann Arbor 37
Dong Ket 27
Princeton 25
Vienna 25
Villeurbanne 24
Jacksonville 23
Turin 18
Dearborn 17
Fremont 15
Seoul 15
Hangzhou 14
Jakarta 14
Pisa 12
San Diego 11
Shanghai 10
Helsinki 9
Milan 9
Nanjing 9
New York 9
Paris 9
São Paulo 9
Taipei 9
Hefei 8
Warsaw 8
Guangzhou 6
San Mateo 6
Xian 6
Amsterdam 5
Bogotá 5
Brussels 5
Budapest 5
Hong Kong 5
Mountain View 5
Norwalk 5
Ottawa 5
Rome 5
Bayreuth 4
Chengdu 4
Hebei 4
Los Angeles 4
Munich 4
Santa Clara 4
Surbo 4
Tokyo 4
Tong 4
Toronto 4
Upper Marlboro 4
Valencia 4
Villanova 4
Wuhan 4
Zhengzhou 4
Accord 3
Augusta 3
Basel 3
Bengaluru 3
Boardman 3
Boston 3
Brno 3
Cape Town 3
Central District 3
Chennai 3
Chicago 3
Duncan 3
Freudenstadt 3
Hyderabad 3
Kunming 3
Linda-a-velha 3
Lissone 3
Moscow 3
Mumbai 3
Nanchang 3
Northampton 3
Palermo 3
Phoenix 3
Radomsko 3
Rochester 3
Sant Cugat Del Vallès 3
Stockholm 3
Absecon 2
Bologna 2
Campinas 2
Cascina 2
Clifton 2
Collegeville 2
Düsseldorf 2
Totale 1.685
Nome #
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives 280
An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation 255
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib 194
FLAI induction regimen in elderly patients with acute myeloid leukemia 187
Can pegylated interferon improve the outcome of polycythemia vera patients? 173
Anemia in the Elderly: not Always what it Seems. 145
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice 136
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice 122
THE COMBINATION OF FLUDARABINE + CITARABINE + IDARUBICIN (FLAI) IS A SAFE AND EFFECTIVE TREATMENT FOR ELDERLY PATIENTS WITH AML OR HIGH RISK MDS 117
TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS 97
IMATINIB DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON PATIENTS IN CLINICAL PRACTICE 88
Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications 88
IMATINIB DISCOTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON 28 UNSELECTED PATIENTS 86
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience 78
CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET 76
Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm. 74
A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib. 73
Biomarkers for acute and chronic graft versus host disease: state of the art 73
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation 61
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia 60
How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience 56
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation 55
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience 49
null 37
Optimal delivery of follow-up care after allogeneic hematopoietic stem-cell transplant: Improving patient outcomes with a multidisciplinary approach 31
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study 28
Totale 2.719
Categoria #
all - tutte 7.579
article - articoli 0
book - libri 0
conference - conferenze 1.552
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020330 0 0 7 29 18 26 30 40 88 44 21 27
2020/2021630 18 56 45 47 40 29 51 64 67 45 80 88
2021/2022495 27 40 29 61 35 25 28 22 16 35 101 76
2022/2023583 54 67 19 62 42 135 38 48 48 15 39 16
2023/2024239 28 43 8 19 16 36 3 13 1 13 32 27
2024/202578 12 38 28 0 0 0 0 0 0 0 0 0
Totale 2.719